Oncology & Cancer

Darolutamide boosts survival in nonmetastatic prostate cancer

(HealthDay)—For men with nonmetastatic, castration-resistant prostate cancer, the risk for death is significantly lower for those receiving darolutamide versus placebo, according to a study published in the Sept. 10 issue ...

Cardiology

First treatment identified for fainting

Fainting affects one in two people during their lifetime. Those with recurrent episodes are often afraid to socialise or go to work. Today researchers report the first effective therapy. The late breaking research is presented ...

Medications

Gout drug repurposed to fight heart disease

Colchicine reduces the risk of major cardiovascular events in patients with chronic coronary disease, according to results of the LoDoCo2 trial presented in a Hot Line session today at ESC Congress 2020.

Medications

Evinacumab cuts LDL-C level in familial hypercholesterolemia

(HealthDay)—For patients with homozygous familial hypercholesterolemia, evinacumab lowers low-density lipoprotein (LDL) cholesterol levels, according to a study published in the Aug. 20 issue of the New England Journal ...

Neuroscience

Concussions can cause long-term sleep problems

A new study shows that people who have had concussions sometimes develop long-term after effects, including sleep disturbances. The findings could also be of use to other patient groups.

page 34 from 40